These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26006759)

  • 1. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
    Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
    Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives.
    Makam P; Thakur PK; Kannan T
    Eur J Pharm Sci; 2014 Feb; 52():138-45. PubMed ID: 24231338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
    Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
    Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
    Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
    Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
    Sharma R; Patil S; Maurya P
    SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
    Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
    Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrP(C) to PrP(Sc).
    Pagadala NS; Perez-Pineiro R; Wishart DS; Tuszynski JA
    Eur J Med Chem; 2015 Feb; 91():118-31. PubMed ID: 25042003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aminoquinoline-pyrimidine hybrids: synthesis, antimalarial activity, heme binding and docking studies.
    Kumar D; Khan SI; Tekwani BL; Ponnan P; Rawat DS
    Eur J Med Chem; 2015 Jan; 89():490-502. PubMed ID: 25462261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents.
    Vyas VK; Bhati S; Sharma M; Gehlot P; Patel N; Dalai S
    SAR QSAR Environ Res; 2023; 34(8):639-659. PubMed ID: 37651746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
    Zhang S; Hou B; Yang H; Zuo Z
    Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
    Kannan M; Raichurkar AV; Khan FR; Iyer PS
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1100-3. PubMed ID: 25650255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) and molecular docking study of thienopyrimidine and thienopyridine derivatives to explore structural requirements for aurora-B kinase inhibition.
    Borisa A; Bhatt H
    Eur J Pharm Sci; 2015 Nov; 79():1-12. PubMed ID: 26343315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
    Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
    Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three 4-aminoquinolines of antimalarial interest.
    Bourne SA; De Villiers K; Egan TJ
    Acta Crystallogr C; 2006 Feb; 62(Pt 2):o53-7. PubMed ID: 16456284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis.
    Li J; Li S; Bai C; Liu H; Gramatica P
    J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.
    Vyas VK; Ghate M
    SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.